Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,385–3,392 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Protagonist Therapeutics Inc. PN-235 (JNJ-77242113) - (FRONTIER 1) Plaque psoriasis Phase 2b Data Released Oral Immunology: Anti-TNF
Protagonist Therapeutics Inc. PTG-100 Ulcerative colitis Phase 2b Trial Discontinued Oral Gastroenterology
Protagonist Therapeutics Inc. Rusfertide (PACIFIC) Polycythemia Vera (PV) Phase 2 Data Released Subcutaneous Hematology
Protagonist Therapeutics Inc. Rusfertide - (REVIVE) Polycythemia vera Phase 2 Data Released Subcutaneous Hematology
Protagonist Therapeutics Inc. Rusfertide (PTG-300) Hereditary hemochromatosis Phase 2 Trial Planned Subcutaneous Genetic Disorder
Protagonist Therapeutics Inc. PN-943 - (IDEAL) Ulcerative colitis Phase 2 Trial Discontinued Oral Gastroenterology
Protagonist Therapeutics Inc. PTG-200 Crohn's disease Phase 2 Trial Discontinued oral Gastroenterology
Protagonist Therapeutics Inc. Rusfertide (PTG-300) Beta-thalassemia Phase 2 Trial Discontinued Subcutaneous Genetic Disorder